Safety and efficacy of low-molecular-weight heparin in pregnant women at risk of venous thromboembolism: Prospective cohort study - Forschungsportal der Justus-Liebig-Universität Gießen:

Meeting Abstract

Safety and efficacy of low-molecular-weight heparin in pregnant women at risk of venous thromboembolism: Prospective cohort study

Autorenliste: Bauersachs, RM; Dudenhausen, J; Faridi, A; Fischer, T; Fung, S; Geisen, U; Harenberg, J; Herchenhan, E; Keller, F; Kemkes-Matthes, B; Schinzel, H; Spannagl, M; Thaler, CJ

Jahr der Veröffentlichung: 2005

Seiten: 149-149

Zeitschrift: Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis

Bandnummer: 115

ISSN: 0049-3848

Konferenz: International Symposium on Womens Health Issues in Thrombosis and Hemostasis

Verlag: Elsevier

Zitierstile

Harvard-Zitierstil: Bauersachs, R., Dudenhausen, J., Faridi, A., Fischer, T., Fung, S., Geisen, U., et al. (2005) Safety and efficacy of low-molecular-weight heparin in pregnant women at risk of venous thromboembolism: Prospective cohort study, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis, 115, p. 149

APA-Zitierstil: Bauersachs, R., Dudenhausen, J., Faridi, A., Fischer, T., Fung, S., Geisen, U., Harenberg, J., Herchenhan, E., Keller, F., Kemkes-Matthes, B., Schinzel, H., Spannagl, M., & Thaler, C. (2005). Safety and efficacy of low-molecular-weight heparin in pregnant women at risk of venous thromboembolism: Prospective cohort study. Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis. 115, 149.

Nachhaltigkeitsbezüge